Glimicut MP 2mg/500mg/15mg Tablet SR
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimicut MP 2mg/500mg/15mg Tablet SR
Metformin/glimepiride/pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose. Used alongside diet and exercise in adults with type 2 diabetes, this medication enhances insulin effectiveness, thus reducing blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Administer with food to mitigate gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular regimen. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or meal skipping elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Baseline kidney function testing will be performed before treatment initiation. Limit alcohol consumption to minimize potential side effects.
Uses of Glimicut MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimicut MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicut MP 2mg/500mg/15mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimicut MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimicut MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimicut MP 2mg/500mg/15mg Tablet SR whole; do not bite, pulverize, or fracture it. Administer this medicine with a meal.
How Glimicut MP 2mg/500mg/15mg Tablet SR works:
Glimicut MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach improves blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this by further improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimicut MP 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimicut MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimicut MP 2mg/500mg/15mg tablet likely poses a breastfeeding safety risk. Available human data indicate potential drug transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimicut MP 2mg/500mg/15mg SR tablets cautiously, as dose modification may be necessary. Severe kidney disease contraindicates the use of Glimicut MP 2mg/500mg/15mg SR tablets. Medical supervision, including regular kidney function tests, is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glimicut MP 2mg/500mg/15mg SR tablets. Dosage modification may be necessary; physician consultation is advised. Glimicut MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimicut MP 2mg/500mg/15mg Tablet SR :
Should you forget a Glimicut MP 2mg/500mg/15mg Tablet SR dose, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Glimicut MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently